A Primer on Arrhythmias in Patients with Hypertrophic Cardiomyopathy
- 24 July 2012
- journal article
- review article
- Published by Springer Nature in Current Cardiology Reports
- Vol. 14 (5) , 552-562
Abstract
Patients with hypertrophic cardiomyopathy are at risk of atrial and ventricular arrhythmias, yet treatment options for these patients are made almost solely by extrapolation from patients with other diseases. Heart block may be seen spontaneously but is especially prevalent following septal reduction strategies. Atrial fibrillation is the most common arrhythmia in patients with hypertrophic cardiomyopathy. The onset of atrial fibrillation often represents a turning point clinically for patients, marked by substantial functional deterioration and morbidity. Sudden cardiac death is the most common cause of death in the young patient, but still contributes to mortality in older patients. Major risk factors for sudden cardiac death include resuscitated sudden cardiac death, marked hypertrophy, syncope, and family history of sudden cardiac death due to hypertrophic cardiomyopathy. Minor risk factors for sudden cardiac death include nonsustained ventricular tachycardia, and hypotensive response to exercise. Emerging possible risk factors include atrial fibrillation, myocardial ischemia, left ventricular outflow tract obstruction, genetic mutations, left ventricular apical aneurysms, myocardial fibrosis, and end stage disease.Keywords
This publication has 96 references indexed in Scilit:
- Characteristics and Clinical Significance of Late Gadolinium Enhancement by Contrast-Enhanced Magnetic Resonance Imaging in Patients With Hypertrophic CardiomyopathyCirculation: Heart Failure, 2010
- CMR findings in patients with hypertrophic cardiomyopathy and atrial fibrillationJournal of Cardiovascular Magnetic Resonance, 2009
- Cardiac troponin T mutations promote life-threatening arrhythmiasJournal of Clinical Investigation, 2008
- Myofilament Ca2+ sensitization causes susceptibility to cardiac arrhythmia in miceJournal of Clinical Investigation, 2008
- Genetic Basis of Hypertrophic Cardiomyopathy: From Bench to the ClinicsJournal of Cardiovascular Electrophysiology, 2007
- Determinants of implantable defibrillator discharges in high-risk patients with hypertrophic cardiomyopathyHeart, 2007
- Evidence that pharmacological strategies lack efficacy for the prevention of sudden death in hypertrophic cardiomyopathyHeart, 2007
- P-wave durations as a predictor for atrial fibrillation development in patients with hypertrophic cardiomyopathyInternational Journal of Cardiology, 2004
- Toward clinical risk assessment inhypertrophic cardiomyopathy withgadolinium cardiovascular magnetic resonanceJACC, 2003
- De subitaneis mortibus. XII. Asymmetrical hypertrophy of the heart.Circulation, 1975